Co-administration of 5α-reductase Inhibitors Worsens the Adverse Metabolic Effects of Prescribed Glucocorticoids.
Othonos N, Marjot T, Woods C, Hazlehurst JM, Nikolaou N, Pofi R, White S, Bonaventura I, Webster C, Duffy J, Cornfield T, Moolla A, Isidori AM, Hodson L, Tomlinson JW.
Othonos N, et al.
J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3316-28. doi: 10.1210/clinem/dgaa408.
J Clin Endocrinol Metab. 2020.
PMID: 32594135
Free PMC article.
Clinical Trial.